Back to results
US 2024/0189419 A1Published application
Method for the prophylaxis or treatment of coronavirus infection using an immunomodulator and vaccine compositions comprising the same
AssigneeAdvagene Biopharma Co., Ltd.
InventorsYU-SHEN HSU, SSU-WEI KANG, MING-I CHANG
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a method for the treatment or prophylaxis of coronavirus infection, comprising administering a therapeutically effective amount of an immunomodulator to a subject in need thereof or at risk of coronavirus infection. A vaccine composition comprising a pharmaceutically effective amount of an immunomodulator is also provided.
Claims5
1-13. (canceled)
A method for inducing IFNα production in epithelial cells of a subject, comprising administering the epithelial cells of the subject a therapeutically effective amount of an immunomodulator.
Dependencies are inferred from the claim text.